{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-06b1bc-2026-06-10T12:36:02+01:00",
    "date": "2026-06-10T12:36:02+01:00",
    "ocid": "ocds-h6vhtk-06b1bc",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PDBY-6395-VWBP",
            "name": "NHS Blood and Transplant",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PDBY-6395-VWBP"
            },
            "address": {
                "streetAddress": "500 North Bristol Park",
                "locality": "Bristol",
                "postalCode": "BS34 7QH",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKK12"
            },
            "contactPoint": {
                "email": "rowena.thomas@nhsbt.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.nhsbt.nhs.uk/",
                "classifications": [
                    {
                        "id": "publicAuthorityCentralGovernment",
                        "scheme": "UK_CA_TYPE",
                        "description": "Public authority - central government"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PDBY-6395-VWBP",
        "name": "NHS Blood and Transplant"
    },
    "planning": {
        "milestones": [
            {
                "id": "engagement",
                "type": "engagement",
                "description": "Interested suppliers are asked to express their interest to rowena.thomas@nhsbt.nhs.uk by 5pm on Friday, 10th July 2026. Suppliers expressing an interest will be invited to attend an early market engagement exercise supplier meeting during the week of the 3rd August 2026 (note: date subject to change). Prior to this session, interested suppliers will be provided with a draft specification of requirements and short questionnaire related to requirements. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position.",
                "dueDate": "2026-07-10T23:59:59+01:00",
                "status": "scheduled"
            }
        ],
        "documents": [
            {
                "id": "054707-2026",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/054707-2026",
                "datePublished": "2026-06-10T12:36:02+01:00",
                "format": "text/html"
            }
        ]
    },
    "tender": {
        "id": "C452579",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "External Quality Control Testing (for Cellular and Molecular Therapies)",
        "description": "NHS Blood and Transplant is seeking to engage with the market in relation to the provision of external Quality Control testing services to support the Clinical Biotechnology Centre in the development and production of Advanced Therapeutic Investigational Medicinal Products, biotechnology products and biological products. The requirement is expected to include specialist QC testing services for in-process, final product and cell bank testing, with testing capabilities potentially including mycoplasma testing, bacterial cell bank testing, mammalian cell bank testing, specialised viral safety testing, viral clearance studies, sterility testing and cell-based sterility testing. The precise testing requirements may vary by project and NHSBT may require the ability to add or remove tests during the contract term. Suppliers would be expected to operate under appropriate regulatory and quality standards, including GMP and, where applicable, GLP, and to provide validated assays, appropriate quality documentation, Certificates of Analysis, comprehensive reports, support for quality technical agreements, audit access and out of specification investigations.",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "72225000",
                        "description": "System quality assurance assessment and review services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKK11",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amountGross": 2000000,
            "amount": 1600000,
            "currency": "GBP"
        },
        "mainProcurementCategory": "services",
        "aboveThreshold": true,
        "lots": [
            {
                "id": "1",
                "suitability": {
                    "sme": true
                },
                "contractPeriod": {
                    "startDate": "2027-01-01T00:00:00Z",
                    "endDate": "2030-12-31T23:59:59Z",
                    "maxExtentDate": "2032-12-31T23:59:59Z"
                },
                "hasRenewal": true,
                "status": "planning"
            }
        ],
        "communication": {
            "futureNoticeDate": "2026-09-14T23:59:59+01:00"
        },
        "status": "planning"
    },
    "language": "en"
}